Fang: SacTMT in EGFR OptiTroplung04. Note no Osi in either arm. OS primary endpoint. Impressive benefit, but there are some nuances. Less subsequent therapies, more tox in Sac arm. But 7month benefit hard to ignore these results
#LCSM #ESMO26